ZVS-203e

N/A

Report date: 2025/10/21 14:22:56

Base Information

Drug NameZVS-203e
Drug Alias NameZVS-203-eZVS203e
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV8 vectorCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas9
Mechanisms of ActionRHO gene transference
TargetsRhodopsin
Therapy Area/IndicationsAutosomal Dominant DisorderRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Chinagene Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesThe Third Affiliated Hospital Of Beijing UniversityBeijing Zhongyin Pharmaceutical Co LtdChigenovo Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsAutosomal Dominant DisorderRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A